Aurora EV ICD (DVEA3E4)
Medtronic, Inc. is listed for Aurora EV ICD (DVEA3E4) (P220012/S059). The FDA list gives October 28, 2025 as the date of the final decision. The lead panel is Cardiovascular, and the database link on the FDA list is the PMA pathway. openFDA describes product code LWS as “Implantable Cardioverter Defibrillator (Non-Crt)”: These devices treat tachycardia (fast heartbeats) with RV defibrillation therapy as necessary. This paragraph is assembled only from those public fields. It is not an FDA review, not a determination of safety or effectiveness, and not medical advice. Official record: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P220012S059
- Date of final decision
- October 28, 2025
- Company on the FDA list
- Medtronic, Inc.
- Lead panel
- Cardiovascular
- Primary product code
- LWS
- openFDA device name for the code
- Implantable Cardioverter Defibrillator (Non-Crt)
- Device class
- 3
- Regulation number
- Not returned
- openFDA decision description
- Not returned
- openFDA decision code
- Not returned
- Statement or summary label
- Not returned
Product-code text from openFDA
These devices treat tachycardia (fast heartbeats) with RV defibrillation therapy as necessary.
Other listings for this company
- K233562 · LINQ II Insertable Cardiac Monitor
- K230553 · LINQ II Insertable Cardiac Monitor, CareLink SmartSync LINQ II ICM Application
- K223630 · Reveal LINQ Insertable Cardiac Monitor, LINQ II Insertable Cardiac Monitor, AccuRhythm AI ECG Classification System
- K221962 · LINQ II Insertable Cardiac Monitor
- K210484 · LINQ II Insertable Cardiac Monitor, Zelda AI ECG Classification System
- K162855 · Reveal LINQ